Kontafarma China Holdings Ltd

As of December 31, 2024, Kontafarma China Holdings Ltd carries a market capitalization of 145.30M, placing it among publicly traded companies globally. Its enterprise value stands at 334.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, Kontafarma China Holdings Ltd has 5.59B shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Kontafarma China Holdings Ltd maintains a current ratio of 1.26, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Kontafarma China Holdings Ltd's stock has gained approximately 3.45% over the past 52 weeks. The 50-day moving average sits at 0.03, while the 200-day moving average is 0.03.

As of December 31, 2024, Kontafarma China Holdings Ltd holds 90.59M in cash and equivalents against 297.19M in total debt, resulting in a net debt position of 7.47M. Total book value stands at 978.70M, with working capital of 114.70M providing operational flexibility.

Kontafarma China Holdings Ltd's most recent stock split took place on February 3, 2015 with a 1:5 split ratio.